Industry News

Masimo announced today that University Hospitals Geneva Medical Center, a Critical Access Hospital in Geneva, Ohio, is building a hospital-wide wireless monitoring and clinician notification system using Masimo Patient SafetyNet™* in conjunction with Masimo Root ® with Radius-7 ® and Masimo Radical-7 ®. UH Geneva is part of University Hospitals, based in Cleveland, Ohio. This Smart News Release features multimedia."/>
Leading Ohio Critical Access Hospital Adopts Masimo Root® with Radius-7®, Radical-7®, and Patient SafetyNet™ to Create Hospital-Wide Wireless Monitoring and Clinician Notification System
KemPharm, Inc., a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, announced today that its president and chief executive officer, Travis C. Mickle, Ph.D., will present at the Canaccord Genuity 36 th Annual Growth Conference being held August 10-11, 2016, at the InterContinental Boston Hotel.. Details of KemPharm's presentation are as follows:. Date: Thursday, August 11, 2016 Time:..."/>
KemPharm to Present at Canaccord Genuity 36th Annual Growth Conference
Fibrocell Science, Inc. will report financial results for the second quarter ended June 30, 2016 and recent operational highlights on Thursday, August 4, 2016, before the open of the U.S. financial markets. Fibrocell will also host a conference call and webcast at 8:30 a.m. EDT on the same day to discuss its financial results and operational highlights. A question-and-answer session will follow Fibrocell’ s remarks.."/>
Fibrocell to Host Conference Call and Webcast on Thursday, August 4, 2016 to Discuss Second Quarter 2016 Financial Results and Recent Operational Highlights
Exact Sciences Corporation today announced the upsizing and pricing of its previously announced underwritten public offering of common stock. The Company is selling 8,500,000 shares of common stock through the underwriters at a public offering price of $15.50 per share. The offering was increased to 8,500,000 shares from the previously announced offering of 7,000,000 shares due to market demand."/>
Exact Sciences Announces Upsizing and Pricing of Public Offering of Common Stock
AdCare Health Systems, Inc.,, a self-managed healthcare real estate investment company that invests primarily in real estate purposed for senior living and long-term healthcare, today announced that management expects to report financial results for the second quarter of 2016 on Monday, August 15, 2016 before the market opens. Management will conduct a conference call on Monday, August 15, 2016 at 10 a.m. ET to discuss the results."/>
AdCare Schedules Conference Call to Discuss Second Quarter Financial Results
Catabasis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, will report second quarter 2016 financial results after the NASDAQ Global Market close on Thursday, August 11, 2016. Jill C. Milne, Ph.D., Chief Executive Officer, will host a conference call and webcast at 4:30pm ET to provide an update on corporate developments and to discuss second quarter financial results."/>
Catabasis Pharmaceuticals to Report Second Quarter 2016 Financial Results and Recent Corporate Developments on Thursday, August 11
Karyopharm Therapeutics Inc., a clinical-stage pharmaceutical company, announced today that it will report second quarter 2016 financial results and provide a company update on Thursday, August 4, 2016. Karyopharm’ s management team will host a conference call and audio webcast at 8:30 a.m. ET on Thursday, August 4, 2016 to discuss the financial results and recent business developments.. To access the conference call, please dial 437-4406 or 756-4292..."/>
Karyopharm to Report Second Quarter 2016 Financial Results on August 4, 2016
RTI Surgical, Inc., today publishes an open letter following the company's July 27 earnings warning, its fourth in three years. Curtis M. Selquist Chairman RTI Surgical, Inc. 11621 Research Circle Alachua, FL 32615. Congratulations on your victory against Krensavage Asset Management LLC and its efforts to protect the shareholder through our failed proxy fight."/>
Krensavage Poses Questions to RTI Surgical in Open Letter
Cara Therapeutics, Inc., a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting peripheral kappa opioid receptors, today announced that the Company will host a conference call and live audio webcast on Thursday, August 4, 2016, at 4:30 p.m. ET to report second quarter 2016 financial results and provide a corporate update.. To participate in the..."/>
Cara Therapeutics to Announce Second Quarter 2016 Financial Results on August 4, 2016
CAS Medical Systems, Inc., a leader in medical devices for non-invasive patient monitoring, announces that it will report financial results for the second quarter of 2016 on Thursday, August 4, 2016, prior to the market’ s opening. Management will host a conference call to discuss these results and answer questions at 10:00 a.m. Eastern time that day.. Conference call dial-in information is as follows:."/>
CASMED to Report Second Quarter 2016 Financial Results and Hold Conference Call on August 4
Diplomat Pharmacy, Inc. is recognizing World Hepatitis Day with a campaign to raise awareness of the disease and honor patients who have felt its effects. World Hepatitis Day occurs annually July 28.. Meet Jacque: Conquering Hepatitis as a Diplomat Patient."/>
Diplomat to Recognize Patients with World Hepatitis Day Campaign
Itamar Medical, which develops and markets non-invasive diagnostic medical devices for sleep-related breathing disorders, received FDA clearance to expand the medical indication of WatchPAT for sleep apnea diagnosis. Under this approval, the use of WatchPAT in the USA is permitted from the age of twelve, expanding the previous indication for ages seventeen and older."/>
FDA Clears Expanded Indication for Itamar Medical's WatchPAT™ Sleep Apnea Diagnostic Device for Adolescents
Array BioPharma, a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer, announced it has appointed Jason Haddock as Chief Financial Officer. Haddock's appointment was effective today and he will be replacing David Horin, who had been acting as Array's interim CFO. We wish to thank Mr."/>
Array BioPharma Announces Appointment Of Jason Haddock As Chief Financial Officer
Champions Oncology, Inc., engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced its financial results for the year ended April 30, 2016.. Fourth Quarter and Recent Business Highlights:. Year over year revenue growth of 26% Projected revenue for fiscal 2017 of $16- 18 million of revenue Delivered second consecutive quarter of record TOS..."/>
Champions Oncology Announces Revenue Up 26%, Projects 43% - 60% Growth For Current Fiscal Year
Corium International, Inc. today announced that it will report financial results for the third fiscal quarter ended June 30, 2016 on Thursday, August 4, 2016 after the close of the U.S. financial markets. Corium will host a conference call and live audio webcast at 5:00 p.m. Eastern time, 2:00 p.m. Pacific time to discuss its financial results and recently announced clinical and regulatory developments.. Conference Call and Webcast Details."/>
Corium to Report Third Quarter Fiscal Year 2016 Financial Results on Thursday, August 4, 2016
Genocea Biosciences, Inc., a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced that it will host a conference call and live audio webcast on Thursday, August 4, 2016 at 9:00 a.m. ET to discuss financial results for the second quarter of 2016. Genocea management will provide an update on the Company's recent progress and upcoming milestones.. Interested participants and investors may access the..."/>
Genocea to Host Second Quarter 2016 Financial Results Conference Call & Webcast on August 4, 2016
Editas Medicine, Inc., a leading genome editing company, and Fondazione Telethon and Ospedale San Raffaele, which operate a joint research collaboration known as the San Raffaele Telethon Institute for Gene Therapy, have entered into a scientific collaboration to research and develop genome edited hematopoietic stem cell and T cell therapies. The scientific work at SR-TIGET in Milan, Italy will be led by Luigi Naldini, M.D., Ph.D., SR-TIGET Director,..."/>
Editas Medicine Announces Scientific Multi-Year Collaboration with Fondazione Telethon and Ospedale San Raffaele  
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on the development of a once-daily, oral therapy for the treatment of liver diseases, and SAMIL Pharm. Co., Ltd. today announced the execution of a license agreement for an exclusive, royalty-bearing license for the commercialization of Aramchol™ for the treatment of fatty liver indications including nonalcoholic steatohepatitis, or NASH, in the..."/>
Galmed Pharmaceuticals and SAMIL Pharm Sign a License Agreement for the Commercialization of Aramchol™ in Korea
DarioHealth Corp., a leader in digital health and mobile health solutions and the developer of the Dario Smart Diabetes Management Solution, today announced that it has begun offering the Dario Smart Diabetes Management Solution direct to the consumer in Australia, via its Australian sponsor IBD Consulting. The company is offering consumers the ability to purchase the Dario All in One meter directly online at the website:..."/>
DarioHealth is Now Direct-to-Consumer in Australia
Meridian Bioscience, Inc. today:. reported fiscal 2016 third quarter and first nine months net revenues of $50.7 million and $149.1 million, respectively, increases of 5% and 1%, respectively, from the same periods of the prior fiscal year; reported third quarter operating income of $13.7 million, a decrease of 5% from the same period of the prior fiscal year; reported nine months operating income of $42.5 million, a decrease of 1% from the same period of the..."/>
Meridian Bioscience Reports Third Quarter 2016 Operating Results, Declares Regular Cash Dividend, and Updates Fiscal 2016 Guidance
STRATA Skin Sciences, Inc., a medical technology company dedicated to developing and commercializing innovative products for the diagnosis and treatment of serious dermatological disorders, will release second quarter financial results on Thursday, August 11, after the market close. STRATA Skin Sciences President and Chief Executive Officer, Michael Stewart, and Christina Allgeier, Chief Financial Officer, will host a conference call at 4:30 pm..."/>
STRATA Skin Sciences, Inc. to Report 2nd Quarter 2016 Financial Results on Thursday, August 11
Five Star Quality Care, Inc. today announced that it will issue a press release containing its second quarter 2016 financial results before the Nasdaq opens on Thursday, August 4, 2016. Eastern Time that morning, President and Chief Executive Officer Bruce Mackey, Chief Financial Officer Rick Doyle and Chief Operating Officer Scott Herzig will host a conference call to discuss these results. The conference call telephone number is 329-4332. Participants..."/>
Five Star Quality Care, Inc. Second Quarter 2016 Conference Call Scheduled for Thursday, August 4th
HeartWare International, Inc., a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced total revenue of $68.7 million for the quarter ended June 30, 2016, compared to $73.6 million for the same period in 2015 and $55.1 million for the first quarter of 2016. Total revenue decreased approximately 7% year-over-year, which is..."/>
HeartWare International Reports $68.7 Million In Second Quarter 2016 Revenue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Most Popular Sectors in the News
Sectors Articles in the last 7 days
Financials816 Articles
Information Technology782 Articles
Consumer Discretionary675 Articles
Industrials525 Articles
Health Care477 Articles

Sponsored Financial Commentaries

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.